Evaluating the Need for Pneumatic Compression Devices
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
For patients undergoing total hip and knee arthroplasty, does the use of Aspirin alone
compared to using Aspirin along with a mobile compression device provide equivocal results
for preventing Deep Vein Thrombosis (DVT) and pulmonary embolism (PE) after total joint
arthroplasty? The investigator will evaluate the prevention of DVT/PE after total hip and
knee arthroplasty will be evaluated to see if there is a decreased risk of bleeding while
continuing to prevent thromboembolic disease. The equivalency of using the mobile compression
devices with aspirin compared to aspirin alone in patients undergoing total hip and knee
arthroplasty will be evaluated. A previous study has shown that patient compliance with the
pneumatic compression device is less than 80%.